Back to Search
Start Over
Recent updates and developments in PET imaging of prostate cancer
- Source :
- Abdominal Radiology. 45:4063-4072
- Publication Year :
- 2020
- Publisher :
- Springer Science and Business Media LLC, 2020.
-
Abstract
- A number of positron emission tomography (PET) radiotracers have been developed to improve the sensitivity and specificity of imaging for prostate cancer. These radiotracers include the bone-seeking agent Na18F as well as more tumor-specific compounds such as 11C-choline and 18F-fluciclovine. In this review, we will discuss the advantages and disadvantages of these PET radiotracers for the imaging of men with prostate cancer across a range of clinical contexts. We will also touch upon radiotracers in late clinical development that have not gained regulatory approval, including those targeted against prostate-specific membrane antigen (PSMA) and gastrin-releasing peptide receptor (GRPR).
- Subjects :
- Male
Oncology
medicine.medical_specialty
Peptide receptor
Urology
Choline
030218 nuclear medicine & medical imaging
03 medical and health sciences
Prostate cancer
0302 clinical medicine
Internal medicine
medicine
Humans
Radiology, Nuclear Medicine and imaging
Membrane antigen
Radiological and Ultrasound Technology
medicine.diagnostic_test
business.industry
Gastroenterology
Prostatic Neoplasms
Pet imaging
medicine.disease
Positron emission tomography
Positron-Emission Tomography
030220 oncology & carcinogenesis
business
Subjects
Details
- ISSN :
- 23660058 and 2366004X
- Volume :
- 45
- Database :
- OpenAIRE
- Journal :
- Abdominal Radiology
- Accession number :
- edsair.doi.dedup.....2fc03a01ed49ed3c6bc24d8fcf2c5210